Cyclo Therapeutics, Inc. Profile Avatar - Palmy Investing

Cyclo Therapeutics, Inc.

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment …

Drug Manufacturers - Specialty & Generic
US, Gainesville [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared Cyclo Therapeutics, Inc. (CYTH) to it's peer group.

Peer Group
Loading...
End of CYTH's Analysis
CIK: 922247 CUSIP: - ISIN: US23254X2018 LEI: - UEI: -
Secondary Listings
CYTH has no secondary listings inside our databases.